Distribution and multi-drug resistance pattern of escherichia coli isolated from patients in federal medical center, Owerri

Authors

  • N.C. J. Anyanwu Department of Microbiology, Faculty of Sciences, Ahmadu Bello University, Zaria, Nigeria
  • W. C. John Federal College of Forestry, Jos, Plateau State, Nigeria
  • C. A. Nsofor Madonna University, Okija, Elele Campus, Rivers State, Nigeria

Keywords:

Escherichia coli; MDR; EMB; Ciprofloxacin; Tetracyclin; Owerri

Abstract

This study was carried out to investigate the distribution and multi-drug resistance (MDR) pattern of Escherichia coli isolated from patients in Federal Medical Centre (FMC), Owerri, Imo State. 255 clinical specimens were collected, including urine, stool, wound swabs, high vaginal swabs, urethral swabs, endocervical swabs, sputum and aspirates. Specimens were cultured on MacConkey agar (MA, Oxoid) and Eosin Methylene Blue Agar (EMB, Oxoid). 100 E. coli isolates were obtained. A significantly high rate of infection was found in females (p<0.05). Susceptibility testing was done on 50 selected isolates using Disc diffusion method with Mueller-Hinton agar. Antibiotics used were Amoxicillin/Clavulanic acid- AMC (30µg), Cefpirome- CPO (30µg), Cefpodoxime- CPD (10µg), Cefotaxime- CTX (30µg), Cefoxitin- FOX (30µg), Ciprofloxacin- CIP (5µg), Tetracyclin- TE (30µg), Nalidixic acid- NA (30µg), Chloramphenicol- C (30µg), Ceftriaxone- CRO (30µg) and Sulphanethoxazole/Trimethoprim- SXT (25µg). Ceftriaxone and Ciprofloxacin had the highest percentage sensitivity (92.0%), while Nalidixic acid and Tetracyclin were the least sensitive (8.0%). Four isolates (8.0%) were resistant to all antibiotics used. This study established that Ceftriaxone and Ciprofloxacin are the most effective drugs for the treatment of E. coli infections in Owerri. However, it is advised that these drugs be taken only on prescription to prevent development of drug resistance.

References

Gold, M., Moellering, D., 2000. A Review of Vaccine Research and Development: Human Enteric Injective. Vaccine., 24 (15), 2732-2750.

Centre for Disease Dynamics, Economics and Policy., 2013. Multi-drug resistant Escherichia coli: Multidrug Resistance is becoming Problematic. Particularly in U.S Southeast., www.cddep.org/home/resistance_map.

International Conference on Antimicrobial Agents and Chemotherapy (ICAAC)., 2012. Prevalence of Multidrug Resistant E. coli rising ICAAC 2 Reports.

Emerenini, E.C., Okolie, P.I., 2012. Mulit-Drug Resistant Pattern and Plasmid Profile of Escherichia coli and other Gram-Negative Bacteria Isolates from Clinical Specimens in Benin City, Nigeria. Afr. J. Microbiol. Res., 6(24), 5091-5094.DOI: 10.5897/AJMR 11.220. ISSN 1996-0808.

McCarty, J.M., Richard, C., Huck, W., et al., 1999. A Randomized Trial of Short-Course Ciprofloxacin, Ofloxacin, or Trimethoprim/Sulfamethoxazole for the treatment of Acute Urinary Tract Infection in Women. Am. J. Med., 106, 292-299.

World Health Organisation., 2009. Enterotoxigenic Escherichia coli (ETEC). http://www.who.org.

Winokur, P.L., Canton, R., Casellas, J.M., et al, 2001. Variations in the Prevalence of Strains Expressing an Extended-Spectrum Beta-Lactamase Phenotype and Characterization of Isolates from Europe, the Americas and the Western Pacific Region. Clin. Infect. Dis., 2, 94-103.

Farooqui, B.J., Shareeq, F., Rizvi, Q K., et al, 2000. Changing Pattern of Antimicrobial Susceptibility of Organisms Causing Community Acquired Urinary Tract Infections. J. Pak. Med. Assoc., 50, 369-373.

Iqbal, M., Patel, I.K., Ain, Q., Barney, N., Kiani, Q., Rabbani, K.Z., Zaidi, G., Mehdi, B. and Shah, S.H. 2002. Susceptibility Pattern of Escherichia coli: Prevalence of Multidrug- resistant Isolates and Extended Spectrum Beta-lactamase Phenotype, JPMA., 52, 407.

Okeke, I.N., Fayinka S.T. Lamikanra, A., 2000. Antibiotics Resistance in Escherichia coli from Nigerian Students. 1986-1998. Emerg. Infect. Dis., 6(4), 393-396.

Rezaee, M.A., Sheikhalizadeh, V., Hasani, A., 2011. Detection of Intergron among Multi- Drug Resistant Escherichia Coli Strains Isolated from Clinical Specimens in Northern West of Iran. Brazil, J. Microbiol., 42(4).

Itokazu, G., 2013. Cephalosporins: A Lecture Note on Cephalosporin Antibiotics. http://www.uic.edu/pharmacy/courses/pmpr342/itokazu/cephalosporins.html.

IF impson, K.S., Weber, D.A., Sanders, C.C. et al., 1990. Beta-Lactamase Production in Members of the Family of Enterobacteriaceae and Resistance to Beta-Lactam-Enzyme Inhibitor Combinations, Antimicrob. Agents Chemother., 34, 622-627.

Khan, S. W. and Ahmed, A. (2001). Uropathogens and Their Susceptibility Pattern: A Retrospective Analysis, J. Pak. Med. Assoc., 51: 98-100.

Talan, D. A., Stam, W. E., Reuning-Scherer, J. et al, (1998). Treatment of Acute Uncomplicated Pyelonephritis (AUP): A Randomized Double-Blind Trail Comparing 7 Vs 14 Day Therapy, Proceeding of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego. California., pp, 24-28.

Downloads

Published

2013-09-29

How to Cite

J. Anyanwu, N., C. John, W., & A. Nsofor, . C. (2013). Distribution and multi-drug resistance pattern of escherichia coli isolated from patients in federal medical center, Owerri. Scientific Journal of Microbiology, 2(9), 179-186. Retrieved from http://sjournals.com/index.php/sjm/article/view/1384

Issue

Vol. 2 No. 9 (2013): September

Section

Original Article

License

Copyright (c) 2013 N.C. J. Anyanwu, W. C. John, C. A. Nsofor

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.